Hypertension improvement and when medication needs revisiting

Hypertension improvement and when medication needs revisiting Writing it up because I had to work it out twice and would rather nobody else did.

Hypertension improvement: setting out the arithmetic in full, because I have had to do it twice and I would rather nobody else did.

Every step is shown. If the answer is wrong the error will be visible, which is the point of writing it out rather than posting the result.

A history of pancreatitis appears in the cautions for this class and the decision around it is one that needs a clinician who knows the history.

Two people can read the same figure differently here and both be reasonable.

Post-authorisation safety studies are the place where under-studied populations eventually appear, and they are public.

Hypertension improvement: I would want to see the raw numbers rather than the summary before agreeing. Summaries lose exactly the information that would settle this.

Building on post #46 rather than restating it.

I think the hypertension improvement question is answerable and has not been answered, which is a more optimistic position than most of this thread.

Confirming post #50 from a second method, which matters more than confirming it from a second person.

Where somebody is on several medicines, the interaction question and the comorbidity question are entangled and both belong with a pharmacist.

Worth reading the earlier posts in this thread before acting on mine.

Where the honest answer is "nobody knows", giving it plainly is more useful than a confident synthesis of mechanism and anecdote.

What would change my mind on hypertension improvement is a second dataset collected by someone with no stake in the first. Until then I hold it loosely and I would rather say so than pretend to more.

Adding the measurement that post #76 says would settle it.

Where a condition is well controlled and where it is not are different questions and the published data rarely distinguishes them.